CDKN2A and cancer: Thus, cytotoxic CD8+ T cells can directly reject Cdkn2a-deficient RT2-cancers, but senescence-induction through IFN-γ-mediated activation of the cell cycle regulators p16Ink4a/p19Arf was strictly needed to control those cancer cells that escape from cytotoxicity.